FONR

Fonar Corporation (FONR)
Healthcare • Diagnostics & Research • $19.09 • MCap: 120,195,888 🌐
https://www.fonar.com • FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company offers an Upright MRI scanner, which allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with legal and regulatory matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.
Buy Decision Core
Total Score
48
Business Quality
11
Financial Strength
13
Growth Outlook
0
Momentum
0
Price Action
Current
19.09
52W High
19.09
52W Low
19.09
Above 50DMA
0 (0%)
Above 200DMA
0 (0%)
Relative Strength
Relative Strength
0
RS 3M
0
RS 6M
0
RS 9M
0
RS 12M
0
Fundamentals
Revenue Growth
-0.03%
Earnings Growth
-0.37%
ROE
0.05%
ROA
0.03%
Valuation
PE (Fwd)
0
PEG
0
P/B
0.71
Upside
0%
Risk
Beta
0.96
Short %
0.01
Risk Score
0
Analyst
Rating
none
Target
0
Beta
0.96
Analysts
0


Total Score
48
Upside
0%
Relative Strength
0
Beta
0.96
Why Buy?
  • PEG Ratio below 1 (attractive valuation)
  • Trading below book value
Key Risks
  • Revenue growth is negative
  • Earnings growth is negative
Score Breakdown
Business
11
Financial
13
Growth
0
Valuation
14
Risk
5
Momentum
0
Technical
52W High: 19.09
52W Low: 19.09
Above 50DMA: 0%
Above 200DMA: 0%
Valuation
Forward PE: 0
PEG: 0
P/B: 0.71
Upside: 0%
Risk
Beta: 0.96
Short Float: 0.01%
ROE: 0.05%
ROA: 0.03%